Risk of disability pension in patients following rectal cancer treatment and surgery

Chen, L.; Glimelius, Ingrid; Neovius, Martin; Eloranta, Sandra; Ekberg, Sara; Smedby, Karin E.

doi:10.1002/bjs.9885

Cited by 20 publications

(27 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a previous Swedish study of cancer patients overall, SL before cancer diagnosis conferred an approximately doubled risk of having SL 5 years after diagnosis (11). In Danish colorectal cancer patients, a significantly lower probability of returning to work was found among those who had previous SL (17).We previously showed that relapse-free rectal cancer patients with prior SL had an 8-fold risk of getting DP compared with general comparators without SL (14). For individuals with a Figure 1.…”

Section: Discussionmentioning

confidence: 85%

“…We have shown in a previous register-based study that a 2-fold increased risk of disability pension (DP) remained among relapse-free rectal cancer patients compared with the population (14). However, if rates of SL are also increased among relapse-free patients, and how they vary by clinical and demographic factors, is unclear.…”

Section: Introductionmentioning

confidence: 97%

“…Among working-age patients, studies have also shown decreased work ability (10)(11)(12)(13)(14)(15)(16)(17)(18). Higher risk of work loss among colorectal cancer survivors (and cancer survivors in general) has been associated with demographic factors such as lower education (10,15,17), unemployment at diagnosis (15), and previous sick leave (SL) episodes (10,15,17).…”

Section: Introductionmentioning

confidence: 99%

“…Given the importance of work loss history as a predictor of continued work loss in other settings (10,11,14,15,18), the patients were stratified by the presence or absence of work loss 1 to 2 years before diagnosis.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss

Chen

Glimelius

Neovius

et al. 2016

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

Background: The number of working-age rectal cancer survivors is increasing due to early detection and improved treatment. However, work loss duration and predictors among them have not been studied thoroughly.Methods: We identified 3,438 patients with stage I-III rectal cancer, 18 to 61 years of age in the Swedish Colorectal Cancer Register 1996-2009. Information on work loss due to sick leave or disability pension was collected from 2 years before diagnosis to 5 years after (until December 31st, 2013). Incidence rate ratios (IRR) of work loss were estimated in a negative binominal model by clinical characteristics for the 1st and 2nd-5th years after diagnosis. Patients were stratified by prediagnostic work loss.Results: Patients without prediagnostic work loss (74%) experienced median 147 days (25th and 75th percentile: 55 and 281) of work loss during the 1st year after diagnosis. Work loss rates

show abstract

Section: Discussionmentioning

confidence: 85%

Section: Introductionmentioning

confidence: 97%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss

Chen

Glimelius

Neovius

et al. 2016

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

show abstract

“…Reported return‐to‐work rates for patients with colorectal cancer range from 60 to 89 per cent. The average duration of sick leave for patients with colorectal cancer in the Netherlands is unknown.…”

Section: Introductionmentioning

confidence: 99%

Predicting return to work among patients with colorectal cancer

Bakker

Anema

Huirne³

et al. 2020

Journal of British Surgery

View full text Add to dashboard Cite

Background:The increase in prevalence of colorectal cancer among young patients coupled with an older retirement age in developed countries means that more patients are being diagnosed with colorectal cancer while still at work. The aim of this study was to develop prediction models for return to work by 1 and 2 years after the start of sick leave.Methods: This was a retrospective registry-based cohort study of data from a nationwide occupational health service in the Netherlands. Only employed patients with colonic or rectal cancer treated with curative intent were included. Two predictor variable models were developed using multivariable logistic regression with backward selection. Calibration, discrimination and explained variance were used to assess model performance, and internal validation by bootstrapping was performed. Results: Median time to return to work for 317 included patients was 423 (95 per cent c.i. 379 to 467) days. Two-thirds of patients had returned to work by 2 years after the start of the sick leave. Presence of metastases, adjuvant treatment, stoma, emotional distress and postoperative complications were predictors of not returning to work in the 1-year model. In the 2-year model, presence of metastases, emotional distress, postoperative complications, company size and the trajectory of the return-to-work process were predictors. Conclusion: Almost 70 per cent of patients with colorectal cancer in this population returned to work within 2 years after the start of sick leave. The models can be used to guide patients early in colorectal cancer treatment about the likelihood of returning to work, and to identify and modify barriers that could facilitate this.

show abstract

Complete Clinical Response in Rectal Cancer After Neoadjuvant Therapy: Organ Preservation Strategies and the Role of Surgery

Fernández¹,

Julião²,

Vailati³

et al. 2019

Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME)

View full text Add to dashboard Cite

Risk of disability pension in patients following rectal cancer treatment and surgery

Abstract: Relapse-free patients with rectal cancer of working age are at risk of disability pension.

Cited by 20 publications

References 22 publications

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss

Predicting return to work among patients with colorectal cancer

Complete Clinical Response in Rectal Cancer After Neoadjuvant Therapy: Organ Preservation Strategies and the Role of Surgery

Contact Info

Product

Resources

About